跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REFIXIA nonacog beta pegol 3000 IU powder and solvent for solution for injection - TGA Drug Approval Details
Approvals
/
TGA
/
REFIXIA nonacog beta pegol 3000 IU powder and solvent for solution for injection
Approved
STANDARD
REFIXIA nonacog beta pegol 3000 IU powder and solvent for solution for injection
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8b0ed223d9606e2b
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
8b0ed223d9606e2b
Product Name
REFIXIA nonacog beta pegol 3000 IU powder and solvent for solution for injection
Artg Id
427218
Artg Name
REFIXIA nonacog beta pegol 3000 IU powder and solvent for solution for injection
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2024-11-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8b0ed223d9606e2b
Type
Standard
Back to TGA Approvals